Skip to main content
. 2017 Feb 1;8(14):23008–23019. doi: 10.18632/oncotarget.14968

Figure 2. MiR-3622b-5p suppresses mTORC1 signaling.

Figure 2

A. and B. miR-3622b-5p overexpression did not alter the activation of RhoA and Rac1 in SK-BR-3 breast cancer cells and SNU-216 gastric cancer cells. The RhoA or Rac1 relative active levels were normalized to the average value of SK-BR-3 or SNU-216 cells transfected with control miRNA. ns, no significance. C. miR-3622b-5p overexpression suppresses the phosphorylation of S6 in SK-BR-3 breast cancer cells and SNU-216 gastric cancer cells. Graphical presentation in the right panel.

HHS Vulnerability Disclosure